What are the unique challenges facing In-Vitro Diagnostic innovators, and how can industry provide better support?
OBN C-Suite Breakfast Discussion, hosted by Syneos
About the topic: The IVD market is rapidly evolving, largely driven by the pandemic and a change in focus to home testing. The process of CE or UKCA marking for IVD medical devices can be challenging, with the need for strong and statistically relevant clinical evidence, demonstrating the safety and performance of each device essential to a successful outcome. During this C-Suite discussion, we will share an update on the current challenges facing IVD Innovators, and how industry can provide better support to maximise the chances of success.
Presenters: The discussion will be introduced by Vesna Sevaljevic, Assoc. Director, Regulatory Affairs at Syneos Health alongside Jonathan Ripley, Principal IVD consultant & Consulting Services Director at IMed Consultancy, and will be followed by a round table discussion between guests.
Event format: OBN's round table C-Suite Discussions are designed exclusively for senior leaders (C-Suite or equivalent) from life sciences organisations, whether R&D or those involved in providing critical support services to the industry. The purpose of these events is to generate some interesting, useful, high-level and boundary pushing discussion and debate, that creates some practical thought-leadership output.
Please note that places are limited and will be offered on an approval only basis.